Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Encouraging quarterly results combined with fresh hopes of economic stimulus measures to lift the benchmarks into the green on Tuesday. Fed chairman Ben Bernanke was critical about the state of the economic recovery which also threatens the employment situation. Benchmarks slipped into negative territory in the morning session following the absence of signals about further monetary measures. However, as market sentiment turned hopeful about such measures in the near future, benchmarks rebounded into the green. In the process, the Dow recorded its best resurgence from the red zone in over five months.
The Dow Jones Industrial Average (DJI) gained 0.6% and closed at 12,805.54. The Standard & Poor 500 (S&P 500) jumped 0.7% and finished yesterday’s trading session at 1,363.67. The tech-laden Nasdaq Composite Index was up 0.5% and ended at 2,910.04. The fear-gauge CBOE Volatility Index dropped 3.7% and settled at 16.48. Consolidated volumes on the New York Stock Exchange, Nasdaq and American Stock Exchange were roughly 6.31 billion shares, slightly higher than the year-to-date daily average of 6.22 billion shares. The advancers outpaced the decliners on the NYSE; as for 65% of gainers, 31% stocks moved lower.
Investors’ hopes for a third round of asset purchases have been dashed every time. The latest Fed minutes also failed to suggest any definite sign of the third quantitative easing (QE3). Federal Reserve Chairman Ben Bernanke painted an extremely grim picture of the financial conditions. Moreover, he did not state anything specific about QE3. Amidst economic weakness, Bernanke also sounded apprehensive about the budget impasse and was concerned about its impact on the economy if the Congress failed to reach an agreement. The labor market is a serious concern and Bernanke noted that the pace of decline in unemployment rate remains “frustratingly slow”.
With such concerns and a grim outlook, benchmarks moved into the negative zone. Further, Bernanke remained elusive about QE3. He did mention central banks considering a range of tools but did not close anything in particular. However, it is generally believed that the Fed will have to announce fresh monetary measures in the near future. Market strategists believed that economic weakness might compel the central bank to take such a step. In the words of the managing director of active trading and derivatives at Charles Schwab, “We know they (Federal Reserve) will. The question is how bad do things have to deteriorate before they act”.
Thus, fresh hopes of QE3 once again lifted investor’ sentiment which was reflected in a market rebound. Also helping the markets finish on a winning note were encouraging earnings results from The Coca-Cola Company (NYSE:KO), Mattel, Inc. (NASDAQ:MAT) and financial heavy weight The Goldman Sachs Group, Inc. (NYSE:GS). While Coco-Cola gained 1.6%, toymaker Mattel’s shares surged a significant 9.7% after second quarter 2012 earnings estimates.
Goldman Sachs joined Citigroup, Inc. (NYSE:C) and JPMorgan Chase & Co. (NYSE:JPM) on the list of companies which bettered earnings estimates, despite flagging global economic conditions. However, Goldman Sachs’ revenues were short of expectations and the company’s shares managed to move up 0.3%.
Coming to the sector-wise performances, materials had a good day with Materials Select Sector SPDR (XLB) gaining 1.3%. Among the stocks, Mosaic Co (NYSE:MOS), PPG Industries, Inc. (NYSE:PPG), E I Du Pont De Nemours And Co (NYSE:DD) and Freeport-McMoRan Copper & Gold Inc. (NYSE:FCX) gaining 5.1%, 2.0%, 1.6% and 0.4%, respectively.
Read the full Analyst Report on KO
Read the full Analyst Report on MAT
Read the full Analyst Report on GS
Read the full Analyst Report on C
Read the full Analyst Report on JPM
Read the full Snapshot Report on MOS
Read the full Analyst Report on PPG
Read the full Analyst Report on DD
Read the full Analyst Report on FCX